Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine versus desloratadine in adults with seasonal allergic rhinitis due to grass pollen
2004-002971-18Phase 4Completed
- Sponsor
- UCB
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Levocetirizine 5 mg once daily with Desloratadine 5 mg once daily (2 arms). Primary endpoint: Subject satisfaction or dissatisfaction after 1 week. Started Oct 2005; status: completed.
02
Drugs
levocetirizinedesloratadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2004-002971-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002971-18.